Institute Resources
Research Centers
The Research Institute at Nationwide Children's Hospital works to enhance the health of children by engaging in high-quality, cutting-edge research. The work we do every day is dedicated to improving the health of Children and their families in Central Ohio and beyond.
A $5 million grant from the National Institutes of Health (NIH) will help researchers at Nationwide Children’s Hospital translate new scientific findings and technological developments into novel treatments for the muscular dystrophies. The grant designates Nationwide Children’s Hospital as a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, one of three national award recipients in 2010.
Read more :: Nationwide Children's Designated as Wellstone Center
A newly funded study is set to determine whether waiting two minutes to clamp a newborn’s umbilical cord after delivery could improve how well he or she recovers from corrective heart surgery.
Read more :: Could Waiting Two Minutes Improve How Newborns Recover from Heart Surgery?
Not all patients with sickle cell disease receive laxatives after being treated with narcotics, despite recommendations from a collaborative panel of pediatric experts. These are the findings from a Nationwide Children’s Hospital study examining patients from 29 pediatric hospitals, and appearing in Pediatric Blood & Cancer.
Read more :: Sickle Cell Patients Should Be Better Monitored for Constipation Prevention
Several newly-identified genes may make children more susceptible to developing autism, according to a study from the Autism Genome Project, an international consortium that includes Nationwide Children’s Hospital. These second-phase results appear in Nature.
Read more :: New Potential Autism Susceptibility Genes Identified
Cynthia Gerhardt, PhD, awarded grant for research to improve care of seriously ill patients
Read more :: Nationwide Children’s Hospital Receives Palliative Care Research Grant
The use of modified measles virus may represent a new treatment for a childhood brain tumor known as medulloblastoma, according to a new study appearing in Neuro-Oncology. Medulloblastoma is the most common malignant central nervous system tumor of childhood, accounting for about 20 percent of pediatric brain tumors.
Hosted by Kevin Flanigan, MD, "This Month in Muscular Dystrophy" podcasts highlight the latest in muscular dystrophy and other inherited neuromuscular disease research. During each podcast, authors of recent publications discuss how their work improves our understanding of inherited neuromuscular diseases, and what their work might mean for treatment of these diseases.
Research News and Highlights
Read more news and highlights from our research faculty